The way content is consumed has changed significantly post-COVID-19. With the move away from traditionally published articles, the preference for short-form publication enhancers (e.g., videos/animated or graphical abstracts, video/audio posters, infographics, and author podcasts) is growing.
To maximize the uptake of medical content, omnichannel approaches to publication planning can provide significant value – offering integrated, personalized content across all platforms and diverse target audiences.
In the full article, Nucleus Global, an Inizio Company, employees Jessica B. Bessler, William Fazzone, Nancy Sladicka, and Adam Ruth explore the platform preferences for consuming published content in medical communications using the results of two recent surveys.
Read the full article here:
https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2240116
Jump to a slide with the slide dots.
Discover five key frontiers reshaping oncology, from biomarker breakthroughs and ctDNA diagnostics to ADC innovations, early intervention, and true..
Read moreDiscover expert-backed strategies to ensure a successful life sciences product launch - align teams, avoid pitfalls, and accelerate market impact.
Read moreDiscover how AI is revolutionizing pharma commercialization in 2025. Learn how Inizio helps life sciences teams scale AI for real-world performance.
Read more